IBUS vs colonoscopy and enterography for UC and CD
Part of Digestive system clinical trials.
This study compares a newer, possibly greener imaging method (IBUS) with standard colonoscopy and enterography for people with ulcerative colitis (UC) or Crohn's disease (CD). The goal is to see if IBUS is as helpful and produces less waste or carbon emissions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a colonoscopy or other endoscopy procedure as part of your care for ulcerative colitis or Crohn's disease.
- You are able to consent to the procedure.
- You are willing to also undergo an IBUS scan (a type of ultrasound) around the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two methods for examining the colon during surveillance colonoscopy in people with inflammatory bowel disease (IBD). One method uses a virtual dye and the other uses a real dye to help detect early signs of cancer. The goal is to see which approach works better and is more comfortable for patients.
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
This trial uses special fluorescent versions of adalimumab and risankizumab to see inflammation in the bowel during an endoscopic procedure. It may help find out which treatment works best for each person's inflammation.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.